Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Catalent
AddedFeb 21, 2024
UpdatedJun 18, 2026
Catalent

Catalent

Public

Catalent, Inc.: A leading global provider of pharmaceutical and biologic solutions, employing over 14,000.

HQ
Somerset, NJ, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Catalent, Inc., founded in 2007 and headquartered in Somerset, New Jersey, is a leading global provider of pharmaceutical and biologic solutions. The company's core mission is to help bring more customer products to market faster, enhancing product performance and ensuring reliable supply. Catalent offers a wide range of services including delivery technologies, drug development, manufacturing, biologics, gene therapies, and consumer health products. With a strong market focus on pharmaceuticals and biotechnology, Catalent serves clients worldwide through its 52 locations.

Notable affiliated individuals include Alessandro Maselli. Catalent is publicly traded on the NYSE under the ticker CTLT and is a component of the S&P 500. Employing over 14,000 people, including approximately 2,400 scientists and technicians, Catalent generated over $3 billion in revenue in fiscal year 2020. The company has made significant impacts in accelerating drug development and enhancing drug delivery technologies, solidifying its position as a critical player in the global pharmaceutical industry.

Catalent - Products & Services

  • Pharmaceutical Contract Packaging logo

    Pharmaceutical Contract Packaging

    Catalent provides pharmaceutical contract development, manufacturing, and packaging services.

Catalent - Similar Companies

FuturePak logo

FuturePak

futurepak.com

Catalyst Pharmaceuticals logo

Catalyst Pharmaceuticals

catalystpharma.com

Societal Cdmo logo

Societal Cdmo

societalcdmo.com

Quintiles logo

Quintiles

quintiles.com

Amphastar Pharmaceuticals logo

Amphastar Pharmaceuticals

amphastar.com

Regeneron Ph logo

Regeneron Ph

regeneron.com

West Pharmaceutical Services I logo

West Pharmaceutical Services I

westpharma.com

AstraZeneca logo

AstraZeneca

astrazeneca.com

Pharma Solutions logo

Pharma Solutions

pharma.solutions

Karyopharm Therapeutics logo

Karyopharm Therapeutics

karyopharm.com

Bristol Myers Squibb logo

Bristol Myers Squibb

bms.com

Lonza logo

Lonza

Collegium Pharmaceutical logo

Collegium Pharmaceutical

ChemRar logo

ChemRar

chemrar.ru

PleoPharma logo

PleoPharma

pleopharma.com

Catalent - Quick Facts

Who are Catalent's competitors?

Companies similar to Catalent include FuturePak, Catalyst Pharmaceuticals, Societal Cdmo and Quintiles.

When was Catalent founded?

Catalent was founded in 2007.

Where is Catalent's headquarters located?

Catalent's headquarters is located in Somerset, NJ, US.

When was Catalent's last funding round?

Catalent's most recent funding round was for $600M (USD) in December 2023.

How much has Catalent raised to-date?

As of Dec 19, 2023, Catalent has raised a total of $1.1B (USD).

How many employees does Catalent have?

Catalent has 19,000 employees as of Feb 4, 2024.

Catalent - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Manufacturing
Revenue
  • Transactional
Customer
  • Enterprise
Tags
  • Pharmaceuticals
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified